| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8624323 | Journal of Oral Biosciences | 2017 | 6 Pages |
Abstract
BMP type II receptor-dependent phosphorylation of ALK2 mutants in response to ligand binding is important for the activation of BMP signaling in FOP. Therefore, the use of anti-activin A compounds would be a novel treatment approach for FOP.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Mai Fujimoto, Naoto Suda, Takenobu Katagiri,